<![CDATA[New Federal Market Access Restrictions: Optimizing Manufacturer Strategies as PBMs Gain Power]]>
Pharmexec·
- Pharmacy benefit managers (PBMs) play a crucial role in the pharmaceutical ecosystem but face increasing scrutiny due to conflicts of interest and opaque revenue sources.
- The 2026 Consolidated Appropriations Act mandates PBMs to pass 100% of rebates to employers and increases transparency around pricing and drug access, altering PBM revenue streams and market dynamics.
- As a result, manufacturers must adapt their strategies, focusing on predictability and direct negotiating tactics to thrive in a transformed landscape where traditional rebate models are reshaped.